BioSpace News Archive

Research from University of California San Francisco and the Mayo Clinic Supports the Use of Fully Automated Volpara®Density™ Software to Inform Women of their Breast Density

Advanced preclinical in vivo models have shown high levels of oral absorption

Obsidian Therapeutics, Inc. announced that two abstracts highlighting preclinical data on the use of its technology for regulation of immunocytokines have been selected for presentation at the 21st Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), taking place May 16-19, 2018, in Chicago, IL.

School-based professionals can register for the new series directly through the Education Resources Inc. website.

Separation designed to unlock value, increase operational performance and strategic flexibility, and tailor capital structure for each business

partnership includes a strategic investment and a worldwide distribution agreement with Merit Medical’s endoscopic division, Merit Medical Endotek®, for NinePoint Medical’s NvisionVLE® Imaging System with Real-time Targeting™

Regulus Therapeutics Inc. announced that it has initiated a Phase I multiple ascending dose (MAD) study in healthy volunteers for RGLS4326 for the treatment of autosomal dominant polycystic kidney disease, or ADPKD

Sensus Healthcare, Inc. announced the appointment of Rita Gable as its Vice President of Sales - Oncology, effective immediately.

The success of biopharmaceutical businesses increasingly hinges on their ability to excel at something that is more typically associated with consumer product goods--namely, creating meaningful brand experiences for consumers, writes Brian McDonagh, a Minneapolis-based strategy director at CBX, in the April issue of BioProcess International magazine.

The US Navy Veterans Mesothelioma Advocate says, “We are urging Navy Veterans who have recently been diagnosed with mesothelioma to not get stuck at the back of the financial compensation line because they hired unqualified or inexperienced lawyer(s) to assist with their bulk payment compensation claim or their VA disability payment.